Vuong Trieu
Chief Executive Officer chez ONCOTELIC THERAPEUTICS, INC.
Fortune : 4 M $ au 31/03/2024
Profil
Vuong Trieu is the founder of IgDraSol, Inc. (founded in 2012) and Oncotelic, Inc. (founded in 2015).
He held the title of Chief Executive Officer at IgDraSol, Inc. from 2012 to 2013.
Currently, Dr. Trieu is the Chairman, President & Chief Executive Officer at Oncotelic, Inc. since 2015.
He is also currently serving as the Chairman, President & Chief Executive Officer at Oncotelic Therapeutics, Inc. since 2019.
Additionally, he holds the position of Chief Executive Officer at Autotelic, Inc., Chairman at IthenaPharma, Inc., President & Director at Stocosil, Inc., and Chief Operating Officer at LipoMedics, Inc. Dr. Trieu is a member of the American Society of Clinical Oncology, Inc., the American Association for Cancer Research, and The Endocrine Society.
In his former positions, he served as the Executive Chairman & Chief Executive Officer at Adhera Therapeutics, Inc. from 2016 to 2018, Director at Sorrento Therapeutics, Inc. in 2013, and Director at Cenomed, Inc. He also held the title of Pharmacology Director at Abraxis BioScience, Inc. and Director-Cardiovascular Biology Program at Parker Hughes Institute.
Dr. Trieu obtained his doctorate degree from the University of Oklahoma in 1989.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ONCOTELIC THERAPEUTICS INC
24,78% | 29/06/2023 | 98 916 746 ( 24,78% ) | 4 M $ | 31/03/2024 |
ADHERA THERAPEUTICS INC
0,06% | 28/04/2023 | 4 311 ( 0,06% ) | 52 $ | 31/03/2024 |
Postes actifs de Vuong Trieu
| Sociétés | Poste | Début |
|---|---|---|
| ONCOTELIC THERAPEUTICS, INC. | Chief Executive Officer | 22/04/2019 |
Stocosil, Inc.
 Stocosil, Inc. Pharmaceuticals: MajorHealth Technology Stocosil, Inc. operates as a pharmaceutical company which develops, manufactures and markets drug therapies. The firm delivers next generation products that treat the double-threat of hypertension and high cholesterol. The company was founded in December 2014 and is headquartered in City of Industry, CA. | President | - |
LipoMedics, Inc.
 LipoMedics, Inc. Pharmaceuticals: MajorHealth Technology LipoMedics, Inc. develops personalized paclitaxel therapy based on its proprietary Therapeutic Drug Monitoring (TDM) device and its platform for delivery of water insoluble drugs including paclitaxel. The company is headquartered in Fort Worth, TX. | Chief Operating Officer | - |
IthenaPharma, Inc.
 IthenaPharma, Inc. Miscellaneous Commercial ServicesCommercial Services IthenaPharma, Inc. engages in the development and commercialization of combination products for pain, arthritis, hypertension, and cancer. The company was founded on September 30, 2014 and is headquartered in Fountain Valley, CA. | Chairman | - |
Oncotelic, Inc.
 Oncotelic, Inc. BiotechnologyHealth Technology Oncotelic, Inc. develops a therapeutic platform for cancer treatments. It conducts registration trials for multiple cancer indications including pancreatic, melanoma, and glioblastoma. The company was founded by Vuong Trieu and Chulho Park and is headquartered in Agoura Hills, CA. | Chief Executive Officer | 01/01/2015 |
Autotelic, Inc.
 Autotelic, Inc. Pharmaceuticals: MajorHealth Technology Autotelic, Inc. manufactures therapeutics drugs. Its Therapeutic Drug Monitoring (TDM) device which allows PK guided dosing, reducing the toxicity from overmedication and increasing the efficacy from under-medication. The company was founded in 2013 and is headquartered in Costa Mesa, CA. | Chief Executive Officer | - |
American Society of Clinical Oncology, Inc.
 American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Corporate Officer/Principal | - |
American Association for Cancer Research
 American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Corporate Officer/Principal | - |
| The Endocrine Society | Corporate Officer/Principal | - |
Anciens postes connus de Vuong Trieu
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░ ░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formation de Vuong Trieu
| University of Oklahoma | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| ONCOTELIC THERAPEUTICS, INC. | Health Technology |
| SORRENTO THERAPEUTICS, INC. | Health Technology |
| ADHERA THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 12 |
|---|---|
Abraxis BioScience, Inc.
 Abraxis BioScience, Inc. Pharmaceuticals: MajorHealth Technology Abraxis Bioscience, Inc. develops therapeutics for cancer, infectious diseases and other critical illnesses. Its development platform uses nanoparticle albumin-bound technology to deliver drugs to tumors that produce SPARC. Abraxene, the first protein-based nanoparticle chemotherapeutic compound, is FDA approved for treating metastatic breast cancer. Abraxis Bioscience is focused on expanding the use of Abraxene and developing other drug candidates utilizing the same technology. Abraxene is approved for marketing in over 35 countris and the company has manufacturing facilities in the United States and Switzerland. Abraxis Bioscience was organized in 2007 from the oncology and research businesses of American Pharmaceutical Partners, Inc. and is headquartered in Los Angeles, CA. | Health Technology |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Health Services |
American Association for Cancer Research
American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Commercial Services |
| The Endocrine Society | |
| Cenomed, Inc. | |
IgDraSol, Inc.
 IgDraSol, Inc. Pharmaceuticals: MajorHealth Technology Part of Cambridge Equities LP, IgDraSol, Inc. is a private company that manufactures cancer therapeutics. The company is based in Fountain Valley, CA. The company was founded by Larn Hwang, Vuong Trieu. IgDraSol was acquired by NantPharma LLC from Sorrento Therapeutics, Inc. on May 15, 2015 for $1,290 million. | Health Technology |
Stocosil, Inc.
Stocosil, Inc. Pharmaceuticals: MajorHealth Technology Stocosil, Inc. operates as a pharmaceutical company which develops, manufactures and markets drug therapies. The firm delivers next generation products that treat the double-threat of hypertension and high cholesterol. The company was founded in December 2014 and is headquartered in City of Industry, CA. | Health Technology |
Oncotelic, Inc.
Oncotelic, Inc. BiotechnologyHealth Technology Oncotelic, Inc. develops a therapeutic platform for cancer treatments. It conducts registration trials for multiple cancer indications including pancreatic, melanoma, and glioblastoma. The company was founded by Vuong Trieu and Chulho Park and is headquartered in Agoura Hills, CA. | Health Technology |
LipoMedics, Inc.
LipoMedics, Inc. Pharmaceuticals: MajorHealth Technology LipoMedics, Inc. develops personalized paclitaxel therapy based on its proprietary Therapeutic Drug Monitoring (TDM) device and its platform for delivery of water insoluble drugs including paclitaxel. The company is headquartered in Fort Worth, TX. | Health Technology |
IthenaPharma, Inc.
IthenaPharma, Inc. Miscellaneous Commercial ServicesCommercial Services IthenaPharma, Inc. engages in the development and commercialization of combination products for pain, arthritis, hypertension, and cancer. The company was founded on September 30, 2014 and is headquartered in Fountain Valley, CA. | Commercial Services |
| Parker Hughes Institute | |
Autotelic, Inc.
Autotelic, Inc. Pharmaceuticals: MajorHealth Technology Autotelic, Inc. manufactures therapeutics drugs. Its Therapeutic Drug Monitoring (TDM) device which allows PK guided dosing, reducing the toxicity from overmedication and increasing the efficacy from under-medication. The company was founded in 2013 and is headquartered in Costa Mesa, CA. | Health Technology |
